Expanded access programs are pathways for patients with serious or life-threatening diseases to access drugs in development outside of clinical trials when there are no other treatment options available. These programs are also known by other names, such as Compassionate Use, Early Access Programs, Managed Access Programs and Named Patient Programs. They are primarily driven by physicians on behalf of their patients.
Andrea Enguita
20 Apr 2026
12 mins read
myTomorrows Team
16 Apr 2026
4 mins read
Stephanie Ferket
15 Apr 2026
15 mins read
myTomorrows Team
26 Mar 2026
5 mins read
Andrea Enguita
25 Mar 2026
8 mins read
Filippo Mandrini
19 Feb 2026
9 mins read
Andrea Enguita
14 Jan 2026
16 mins read
myTomorrows Team
15 Dec 2025
4 mins read
Daniël Groeneweg
27 Nov 2025
8 mins read